Hospitalization rates for ANCA-associated vasculitis (AAV) vary substantially from one country to another, according to a multinational study. Researchers examined hospital records from eight countries, including the U.S., between 2016 and 2022 and found that rates, subtypes, and in-hospital death proportions differed markedly, with Germany and England reporting the…
Discussion
People with the two most common types of ANCA-associated vasculitis (AAV) face a substantially higher risk of cardiovascular disease and thromboembolism (blood clots) than the general population, according to a nationwide Swedish analysis. The study, which compared over 4,000 patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA)…
Discussion
One in seven people with ANCA-associated vasculitis (AAV) has renal arteritis, or inflammation of the small arteries in the kidney, and this condition appears to be associated with an increased risk of kidney failure, a multicenter study in China showed. “The presence of renal arteritis may represent a widespread…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
